PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2024.217402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Mengwei Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China; Shanghai Key Labo…. Hauptthemen laut MEDLINE: Methionine, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Carbon-Sulfur Lyases. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
While metabolic reprogramming and remodeling of tumor microenvironment play important roles in the development of esophageal squamous cell carcinoma (ESCC), the mechanisms remain unclear. In this study, we found that pancreatic progenitor cell differentiation and proliferation factor (PPDPF) is upregulated in ESCC and its expression level is associated with lymph node metastasis. PPDPF was found to promote tumorigenesis, lymph node metastasis and distal metastasis of ESCC cells. Furthermore, the results of mass spectrometry analysis revealed that PPDPF interacts with PCCA, the subunit of the PCC, a key enzyme involved in the catabolism of methionine by the C-Vomit pathway. In addition, PPDPF increases methionine and SAM levels. Additionally, knockdown of PPDPF decreases the levels of methionine and SAM in vivo, and promotes the infiltration of CD8+ T cells in ESCC. Taken together, the results of this study suggest that PPDPF inhibits the interaction between PCCA and PCCB to downregulate methionine catabolism via the C-Vomit pathway, providing a new target for the treatment of ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China; Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai…
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.
- Department of Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.
- College of Public Health, Zhengzhou University, Zhengzhou, 450001, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China. Electronic address: sunyifeng@shchest.org.
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Zhang, Y., Wang, Z., Wang, K., Gao, J., Gu, H., Zeng, Z., Jiang, H., Fan, Q., Zhang, Y., Hu, X., Cui, L., Deng, Y., & Sun, Y. (2025). PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217402
Vancouver
Li M, Zhang Y, Wang Z, Wang K, Gao J, Gu H, et al. PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217402
BibTeX
@article{Li2025,
author = {Li, Mengwei and Zhang, Yi and Wang, Zhexin and Wang, Kai and Gao, Jie and Gu, Haiyong and Zeng, Zimei and Jiang, Haoyao and Fan, Qi and Zhang, Yuxue and Hu, Xudong and Cui, Lingling and Deng, Yuezhen and Sun, Yifeng},
title = {PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2024.217402}
}
EUVIMED